Apply to
Mystic Ventures
Apply To Subscribe
Subscription Amount
$25,000+ Quarterly
Subscription Period
8-24 Quarters
Management Fee
2% per year over 10 years
Carry
20%
Admin Fee
0.15% per year over 10 years
Starting Q1 2025, this fund will transition onto updated Rolling Fund admin fee pricing terms. See the Investment Details section for more.
Invest Account
Select invest account
Note from Jeremy Gardner
What do Peter Thiel, Gov. Rick Perry, Rep. Alexandria Ocasio-Cortez, Tim Ferris, Mike Tyson, Prince Harry, and Elon Musk all have in common?
They either advocate for or directly invest in psychedelic medicine, research, and companies.
The past decade has ushered in a psychedelic renaissance, inspiring a massive push for research, decriminalization, and legalization of these powerful substances. There has been a radical shift in discussions of consciousness expansion, which has broken into the mainstream. With the continued easing of regulatory pressures -- thanks to the growing support of leading experts in healthcare, business, and medical research -- the opportunity to realize the full commercial opportunity and positive social impact of these therapies is now possible.
Mystic Ventures believes the world would be better if more people had access to the healing power of psychedelics. We care about their potential to improve mental health and the human condition. The fund draws on our experiences as entrepreneurs and investors, backing pre-seed and seed-stage startups creating high-quality psychedelic experiences and treatments.
We harness our broad network and abundance of resources to ensure the success of these ventures. Given our reach throughout the investing world, personal relations, social media, and a growing network within the psychedelic space, we are confident that we will have outstanding deal flow and access to any emerging opportunities. In addition, we draw on the expertise of our expansive network which includes some of the most pedigreed physicians, researchers, founders, and entrepreneurs to validate startup theses and conduct due diligence. Still, the focus will be on investing in world-class, dynamic founders.
The psychedelic medicine market is still in its infancy, and every day there is new research published further validating our conviction in these medicines for indications like depression, anxiety, and PTSD. However, there’s also growing interest in the application of these therapies for entirely novel use cases including stroke recovery, chronic pain, bipolar disorder, and even skin inflammation. We are allocating capital to the areas where psychedelics have already begun to show signs of disruption, including:
… But also pioneering investment in areas where Psychedelics are just beginning to show promise:
And so much more.
We chose a Rolling Fund structure in order to reduce the liquidity requirements for limited partners. As of Q2 ‘23, we are deploying close to a million dollars per quarter and seek to double or triple that amount by the year’s end. In addition, whenever possible, we will spin up SPVs for LPs that would like larger exposure to deals or when it's deemed appropriate to make follow-on investments. The fund’s structure allows us to double down on high-conviction bets more quickly and generously spreads out limited partners’ capital commitments.
Jeremy Gardner
Investment Details
Subscription Start Date
October 1, 2024
Minimum Quarterly Subscription
$25,000
Minimum Subscription Period
8 Quarters
Management Fee
Investors pay management fees of 2% per year for the first 10 years.
Management fees are taken as a percentage of the total committed capital. The total management fee is paid out quarterly over the first
four years of the fund's life.
Carry
Twenty percent (20%)
Admin Fee
0.15% per year over 10 years
Starting Q1 2025, this Rolling Fund will transition onto updated Rolling Fund pricing terms. Under these new pricing terms, each new quarterly fund in the Rolling Fund Program will pay an annualized rate of $2.5k + 0.2% of contributed capital over 10 years.
Fees for each quarterly fund in the Rolling Fund Program will vary based on each quarterly fund’s capital contributions since the fee includes a flat fee component. The last quarterly fund in this Rolling Fund Program closed $556.45k in contributed capital. Learn more about how to estimate your commitment’s fees at our help center.
Fees for each quarterly fund in the Rolling Fund Program will vary based on each quarterly fund’s capital contributions since the fee includes a flat fee component. The last quarterly fund in this Rolling Fund Program closed $556.45k in contributed capital. Learn more about how to estimate your commitment’s fees at our help center.
Fund Lead Commitment
Jeremy Gardner's personal subscription per quarter will be at least $50,000. Jeremy Gardner will satisfy their GP commitment in part by waiving a portion of management fees otherwise owed to them by the fund.
Investor FAQ
How is this program different from venture fund investing?
How do subscriptions work?
How do management and admin fees work?
How does carried interest work?
How do distributions work?
Will a Limited Partner (LP) participate in all investments made by the funds offered through this Program?
Will an LP's percentage ownership of quarterly funds always be the same?
Are LPs guaranteed access to Mystic Ventures' future funds?
How are subscriptions funded?
How does changing or canceling a subscription work?
Who manages these funds?
Do funds in this Program have minimum or maximum investment sizes?
What happens if funds in this Program do not invest their total capital each quarter?
When will LPs learn about companies the funds invested in?
Can LPs opt out of specific deals?
Can LPs sell their investment in the fund?
Can LPs redeem their interests in the fund?
When will funds launched under this Program begin deploying capital?
How do I receive tax documents from this Program?
Unanswered questions? Contact AngelList
The performance of past deals or a lead investors' track record is not a guarantee of future returns. Venture capital fund investments are inherently risky and illiquid. Such investments involve a high degree of risk and are suitable only for sophisticated and accredited investors.
AngelList and its affiliates do not provide investment advice to investors. The information on this page should not be relied upon as research, investment advice or a recommendation of any kind. Information on this page is qualified in its entirety by the fund's Limited Partnership Agreement, Private Placement Memorandum and Subscription Agreement, which should be reviewed carefully prior to making an investment decision. Please see these documents for full details regarding risks, minimum investment, fees and expenses. The Fund Lead and the fund's investment advisor have the right to waive or charge additional carry to certain investors. The fund's legal name may be different from the name used above.
This fund may accept new investors after the fund undergoes a valuation update. Certain potential investors in the fund may then have access to materially different information concerning fund value at the time of their investment.
Current or future portfolio companies in this fund may use AngelList's recruiting platform and may pay an affiliate of the fund's investment adviser for premium recruiting tools and services. This may create a potential conflict of interest for the investment adviser, which you will consent to by subscribing to the fund.
Please read the disclosures in full here.
Apply To Subscribe
Subscription Amount
$25,000+ Quarterly
Subscription Period
8-24 Quarters
Management Fee
2% per year over 10 years
Carry
20%
Admin Fee
0.15% per year over 10 years
Starting Q1 2025, this fund will transition onto updated Rolling Fund admin fee pricing terms. See the Investment Details section for more.
Invest Account
Select invest account